CytoMed Therapeutics Limited (GDTC) Return on equity
CytoMed Therapeutics Limited (GDTC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to GDTCSource: SEC XBRL filings · For reference only · Not investment advice
More GDTC financial trends
GDTC RevenueGDTC Net incomeGDTC Net marginGDTC Gross profitGDTC Gross marginGDTC Operating incomeGDTC Operating marginGDTC Operating cash flowGDTC Free cash flowGDTC Capital expendituresGDTC Stock buybacksGDTC Dividends paidGDTC Total assetsGDTC Total liabilitiesGDTC Shareholders’ equityGDTC overview →